6 Leaving no stone unturned in light of the COVID-19 faecal-oral hypothesis? A water, sanitation and hygiene (WASH) perspective targeting low-income countries.

7 The Effects of Vaccines on the Sequelae Rates of Recurrent Infections and the Severity of Pulmonary COVID-19 Infection by Imaging.

8 Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.

9 Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).

10 Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

11 The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.

12 Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures.

13 Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis

14 A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action

15 Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19)

16 Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China

17 Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.

18 The impact of high-flow nasal cannula (HFNC) on coughing distance: implications on its use during the novel coronavirus disease outbreak.

19 Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China

20 Diagnosis and treatment recommendation for pediatric coronavirus disease-19

21 [Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].

22 [Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review].

23 [Follow-up testing of viral nucleic acid in discharged patients with moderate type of 2019 coronavirus disease (COVID-19)].

24 [Oral Health Management of Children during the Epidemic Period of Coronavirus Disease 2019].

25 Coronavirus Disease 2019 as a challenge for maritime medicine.

26 Novel coronavirus disease (COVID-19) outbreak: Now is the time to refresh pandemic plans.

27 Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review.

28 Use of Systemic Immunomodulatory Therapies During the Coronavirus Disease 2019 (COVID-19) Pandemic.

29 Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment.

30 A rapid fatal evolution of Coronavirus Disease-19 (COVID-19) in an advanced lung cancer patient with a long time response to nivolumab.

31 Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

32 CT imaging features of patients with different clinical types of coronavirus disease 2019 (COVID-19)

33 Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?

34 The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China

35 Policies on the use of respiratory protection for hospital health workers to protect from coronavirus disease (COVID-19)

36 Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).

37 Epidemiology and Clinical Features of Coronavirus disease 2019 in Children.

38 Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019.

39 Severe Acute Respiratory Syndrome (SARS) and Coronavirus disease-2019 (COVID-19): From Causes to Preventions in Hong Kong.

40 Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong.

41 Chinese experts’ consensus on the Internet of Things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19)

42 Thalidomide against coronavirus disease 2019 (Covid-19): A medicine with a thousand faces

43 Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports

44 Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review

45 Advanced Preparation Makes Research in Emergencies and Isolation Care Possible: The Case of Coronavirus Disease.

46 Radiologic Findings of Coronavirus Disease (COVID-19): Clinical Correlation Is Recommended.

47 Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic – Case study from the Republic of Ireland

48 Strategies for Prevention of Coronavirus Disease 2019 in the Dental Field.

49 The outbreak of Novel Coronavirus disease (COVID-19) caused a worrying delay in the diagnosis of oral cancer in north-west Italy: the Turin Metropolitan Area experience.

50 Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report.

51 Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review

52 Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States.

53 Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient

54 Features of liver injury in patients with coronavirus disease 2019 in Bozhou, China

55 Addressing the impact of the Coronavirus Disease (COVID-19) pandemic on hematopoietic cell transplantation: Learning networks as means for sharing best practices.

56 Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study.

57 A fourteen-day experience with coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS): An Iranian treatment protocol

58 Blockchain and Artificial Intelligence Technology for Novel Coronavirus Disease-19 Self-Testing.

59 The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease.

60 Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019.

61 Modelling spatial variations of coronavirus disease (COVID-19) in Africa

62 CORONAVIRUS DISEASE (COVID-19) TREATMENT ALGORITHMS IN PATIENTS WITH QT INTERVAL PROLONGATION

63 Risk Stratification and Personal Protective Equipment Use in Pediatric Endoscopy During the Coronavirus Disease 2019 Outbreak: A Single-center Protocol.

64 Pediatric Endoscopy in the Era of Coronavirus Disease 2019: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper.

65 Laparoscopy in the coronavirus disease 2019 (COVID-19) era

66 Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes.

67 Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19).

68 The media and their informative role in the face of the coronavirus disease 2019 (COVID-19): Validation of fear perception and magnitude of the issue (MED-COVID-19)

69 Epidemiological characteristics of new coronavirus diseases (COVID-19): Features of risk factors and clinical features of the child population

70 Coronavirus disease 2019 (COVID-19) pandemic: Review of guidelines for resuming non-urgent imaging and procedures in radiology during Phase II.

71 Comment on "The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region" and reflections from the Italian Association of Oncology Nurses.

72 Clusters of Coronavirus Disease in Communities, Japan, January-April 2020.

73 Overview of Coronavirus Disease 2019 (COVID-19): Treatment Updates and Advances.

74 Cardiac arrest during emergency intubation in an elderly patient with confirmed coronavirus disease 2019

75 The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases.

76 Importance of the evaluation of systemic microvascular flow and reactivity in critically ill patients with coronavirus disease 2019 - COVID-19.

77 Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report.

78 Olfactory Dysfunction in Coronavirus Disease 2019 Patients: Observational Cohort Study and Systematic Review.

79 Clinical and Demographic Characteristics of Cluster Cases and Sporadic Cases of Coronavirus Disease 2019 (COVID-19) in 141 Patients in the Main District of Chongqing, China, Between January and February 2020.

80 Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic.

81 Editorial, Authors Reply: Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community.

82 Clinical characteristics of emergency surgery patients infected with coronavirus disease 2019 (COVID-19) pneumonia in Wuhan, China.

83 [Roles of the public-facility-turned temporary hospital in prevention and control of coronavirus disease 2019 in Wuhan, China and clinical experience in the hospital].

84 Coronavirus disease 2019 (COVID-19) in critically ill patients: can we re-program the immune system? A primer for intensivists

85 A Case Series of Children With Coronavirus Disease 2019: What Have We Learned?

86 Assessment of Community-Level Disparities in Coronavirus Disease 2019 (COVID-19) Infections and Deaths in Large US Metropolitan Areas

87 Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility

88 Severity Detection for the Coronavirus Disease 2019 (COVID-19) Patients Using a Machine Learning Model Based on the Blood and Urine Tests.

89 Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)

90 Prognosis of coronavirus disease 2019 (COVID-19) in patients with HIV infection in New York City

91 Are all patients with cancer at heightened risk for severe Coronavirus Disease 2019 (COVID-19)?

92 Analysis of Epidemiological and Clinical Features in Older Patients With Coronavirus Disease 2019 (COVID-19) Outside Wuhan

93 Airborne or Droplet Precautions for Health Workers Treating Coronavirus Disease 2019?

94 coronavirus disease 2019 (covid–19): a short review on hematological manifestations

95 Incidence of Post-Traumatic Stress Disorder After Coronavirus Disease

96 Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019

97 Serum Antibody Profile of a Patient With Coronavirus Disease 2019 Reinfection

98 Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al

99 Decreased B Cells on Admission Associated With Prolonged Viral RNA Shedding From the Respiratory Tract in Coronavirus Disease 2019: A Case-Control Study

100 Coronavirus Disease 2019 (COVID-19) Response in Zimbabwe: A Call for Urgent Scale-up of Testing to meet National Capacity

101 Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial

Keyword Connections

Journals

Research Groups

Bibliographies